Fibrin to von Willebrand factor ratio in arterial thrombi is associated with plasma levels of inflammatory biomarkers and local abundance of extracellular DNA

The composition of thrombi determines their structure, mechanical stability, susceptibility to lysis, and consequently, the clinical outcome in coronary artery disease (CAD), acute ischemic stroke (AIS), and peripheral artery disease (PAD). Fibrin forms the primary matrix of thrombi intertwined with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thrombosis research 2022-01, Vol.209, p.8-15
Hauptverfasser: Tóth, Erzsébet, Beinrohr, László, Gubucz, István, Szabó, László, Tenekedjiev, Kiril, Nikolova, Natalia, Nagy, Anikó I., Hidi, László, Sótonyi, Péter, Szikora, István, Merkely, Béla, Kolev, Krasimir
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 15
container_issue
container_start_page 8
container_title Thrombosis research
container_volume 209
creator Tóth, Erzsébet
Beinrohr, László
Gubucz, István
Szabó, László
Tenekedjiev, Kiril
Nikolova, Natalia
Nagy, Anikó I.
Hidi, László
Sótonyi, Péter
Szikora, István
Merkely, Béla
Kolev, Krasimir
description The composition of thrombi determines their structure, mechanical stability, susceptibility to lysis, and consequently, the clinical outcome in coronary artery disease (CAD), acute ischemic stroke (AIS), and peripheral artery disease (PAD). Fibrin forms the primary matrix of thrombi intertwined with DNA, derived from neutrophil extracellular traps (NETs), and von Willebrand factor (VWF) bridging DNA and platelets. Here we examined the relative content of fibrin, DNA and VWF in thrombi and analyzed their interrelations and quantitative associations with systemic biomarkers of inflammation and clinical characteristics of the patients. Thrombi extracted from AIS (n = 17), CAD (n = 18) or PAD (n = 19) patients were processed for scanning electron microscopy, (immune)stained for fibrin, VWF and extracellular DNA. Fibrin fiber diameter, cellular components, fibrin/DNA and fibrin/VWF ratios were measured. Patients' age presented as a strong explanatory factor for a linear decline trend of the VWF content relative to fibrin in thrombi from CAD (adjusted-R2 = 0.43) and male AIS (adjusted-R2 = 0.66) patients. In a subgroup of CAD and PAD patients with dyslipidemia and high (above 80%) prevalence of atherothrombosis a significant correlation was observed between the VWF and DNA content in thrombi (adjusted-R2 = 0.40), whereas a 3.7-fold lower linear regression coefficient was seen in AIS patients, in whom the fraction of thrombi of atherosclerotic origin was 57%. Independently of anatomical location, in patients with atherosclerosis the VWF in thrombi correlated with the plasma C-reactive protein levels. The observed interrelations between thrombus constituents and systemic inflammatory biomarkers suggest an intricate interplay along the VWF/NET/fibrin axis in arterial thrombosis. •Fibrin, von Willebrand factor (VWF) and NETs form an intertwined matrix in thrombi.•The positive correlation of VWF and DNA in thrombi is reinforced by atherosclerosis.•At higher DNA content the thrombi of smokers are VWF-richer and fibrin-poorer with thinner fibrin fibers.•The fibrin/VWF ratio in thrombi increases with age.•VWF in thrombi with atherosclerotic etiology correlates positively with plasma CRP-levels.
doi_str_mv 10.1016/j.thromres.2021.11.011
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2604833104</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0049384821005193</els_id><sourcerecordid>2604833104</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3311-a8ca3826f2cd82fe0d6611644fc3d95cdfeb7ede366dc3f613bb5592cfd079983</originalsourceid><addsrcrecordid>eNqFkUFv1DAQhS0EokvhL1Q-ckmwY6-T3KgKBaQKLiCO1sQeq16ceLGdLf0z_Fa8bMuV01y-997MPEIuOGs54-rNri23Kc4Jc9uxjrect4zzJ2TDh35sOtl3T8mGMTk2YpDDGXmR844x3vNx-5ycCTlIyaTakN_Xfkp-oSXSQ1zodx8CTgkWSx2YEhNNUHyklYBUMHkI9G_w5KnPFHKOxkNBS-98uaX7AHkGGvCAIdPoqs4FmGeoTvd08nGG9ANTFdaAEE11g2ldLCwGjzj-KgkMhrAGSPTd58uX5JmDkPHVwzwn367ff7362Nx8-fDp6vKmMUJw3sBgQAydcp2xQ-eQWaU4V1I6I-y4Ndbh1KNFoZQ1wikupmm7HTvjLOvHcRDn5PXJd5_izxVz0bPPx0Vgwbhm3SkmhxrFZEXVCTUp5pzQ6X3y9a57zZk-dqN3-rEbfexGc65rN1V48ZCxTjPaf7LHMirw9gTU5-HBY9LZeKyvsT6hKdpG_7-MP0Typ8c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2604833104</pqid></control><display><type>article</type><title>Fibrin to von Willebrand factor ratio in arterial thrombi is associated with plasma levels of inflammatory biomarkers and local abundance of extracellular DNA</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Tóth, Erzsébet ; Beinrohr, László ; Gubucz, István ; Szabó, László ; Tenekedjiev, Kiril ; Nikolova, Natalia ; Nagy, Anikó I. ; Hidi, László ; Sótonyi, Péter ; Szikora, István ; Merkely, Béla ; Kolev, Krasimir</creator><creatorcontrib>Tóth, Erzsébet ; Beinrohr, László ; Gubucz, István ; Szabó, László ; Tenekedjiev, Kiril ; Nikolova, Natalia ; Nagy, Anikó I. ; Hidi, László ; Sótonyi, Péter ; Szikora, István ; Merkely, Béla ; Kolev, Krasimir</creatorcontrib><description>The composition of thrombi determines their structure, mechanical stability, susceptibility to lysis, and consequently, the clinical outcome in coronary artery disease (CAD), acute ischemic stroke (AIS), and peripheral artery disease (PAD). Fibrin forms the primary matrix of thrombi intertwined with DNA, derived from neutrophil extracellular traps (NETs), and von Willebrand factor (VWF) bridging DNA and platelets. Here we examined the relative content of fibrin, DNA and VWF in thrombi and analyzed their interrelations and quantitative associations with systemic biomarkers of inflammation and clinical characteristics of the patients. Thrombi extracted from AIS (n = 17), CAD (n = 18) or PAD (n = 19) patients were processed for scanning electron microscopy, (immune)stained for fibrin, VWF and extracellular DNA. Fibrin fiber diameter, cellular components, fibrin/DNA and fibrin/VWF ratios were measured. Patients' age presented as a strong explanatory factor for a linear decline trend of the VWF content relative to fibrin in thrombi from CAD (adjusted-R2 = 0.43) and male AIS (adjusted-R2 = 0.66) patients. In a subgroup of CAD and PAD patients with dyslipidemia and high (above 80%) prevalence of atherothrombosis a significant correlation was observed between the VWF and DNA content in thrombi (adjusted-R2 = 0.40), whereas a 3.7-fold lower linear regression coefficient was seen in AIS patients, in whom the fraction of thrombi of atherosclerotic origin was 57%. Independently of anatomical location, in patients with atherosclerosis the VWF in thrombi correlated with the plasma C-reactive protein levels. The observed interrelations between thrombus constituents and systemic inflammatory biomarkers suggest an intricate interplay along the VWF/NET/fibrin axis in arterial thrombosis. •Fibrin, von Willebrand factor (VWF) and NETs form an intertwined matrix in thrombi.•The positive correlation of VWF and DNA in thrombi is reinforced by atherosclerosis.•At higher DNA content the thrombi of smokers are VWF-richer and fibrin-poorer with thinner fibrin fibers.•The fibrin/VWF ratio in thrombi increases with age.•VWF in thrombi with atherosclerotic etiology correlates positively with plasma CRP-levels.</description><identifier>ISSN: 0049-3848</identifier><identifier>EISSN: 1879-2472</identifier><identifier>DOI: 10.1016/j.thromres.2021.11.011</identifier><identifier>PMID: 34844046</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Biomarkers ; Brain Ischemia ; DNA ; Fibrin ; Humans ; Male ; Myocardial infarction ; Neutrophil extracellular traps ; Peripheral artery disease ; Stroke ; Thrombosis ; von Willebrand Factor</subject><ispartof>Thrombosis research, 2022-01, Vol.209, p.8-15</ispartof><rights>2021 The Authors</rights><rights>Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3311-a8ca3826f2cd82fe0d6611644fc3d95cdfeb7ede366dc3f613bb5592cfd079983</citedby><cites>FETCH-LOGICAL-c3311-a8ca3826f2cd82fe0d6611644fc3d95cdfeb7ede366dc3f613bb5592cfd079983</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0049384821005193$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34844046$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tóth, Erzsébet</creatorcontrib><creatorcontrib>Beinrohr, László</creatorcontrib><creatorcontrib>Gubucz, István</creatorcontrib><creatorcontrib>Szabó, László</creatorcontrib><creatorcontrib>Tenekedjiev, Kiril</creatorcontrib><creatorcontrib>Nikolova, Natalia</creatorcontrib><creatorcontrib>Nagy, Anikó I.</creatorcontrib><creatorcontrib>Hidi, László</creatorcontrib><creatorcontrib>Sótonyi, Péter</creatorcontrib><creatorcontrib>Szikora, István</creatorcontrib><creatorcontrib>Merkely, Béla</creatorcontrib><creatorcontrib>Kolev, Krasimir</creatorcontrib><title>Fibrin to von Willebrand factor ratio in arterial thrombi is associated with plasma levels of inflammatory biomarkers and local abundance of extracellular DNA</title><title>Thrombosis research</title><addtitle>Thromb Res</addtitle><description>The composition of thrombi determines their structure, mechanical stability, susceptibility to lysis, and consequently, the clinical outcome in coronary artery disease (CAD), acute ischemic stroke (AIS), and peripheral artery disease (PAD). Fibrin forms the primary matrix of thrombi intertwined with DNA, derived from neutrophil extracellular traps (NETs), and von Willebrand factor (VWF) bridging DNA and platelets. Here we examined the relative content of fibrin, DNA and VWF in thrombi and analyzed their interrelations and quantitative associations with systemic biomarkers of inflammation and clinical characteristics of the patients. Thrombi extracted from AIS (n = 17), CAD (n = 18) or PAD (n = 19) patients were processed for scanning electron microscopy, (immune)stained for fibrin, VWF and extracellular DNA. Fibrin fiber diameter, cellular components, fibrin/DNA and fibrin/VWF ratios were measured. Patients' age presented as a strong explanatory factor for a linear decline trend of the VWF content relative to fibrin in thrombi from CAD (adjusted-R2 = 0.43) and male AIS (adjusted-R2 = 0.66) patients. In a subgroup of CAD and PAD patients with dyslipidemia and high (above 80%) prevalence of atherothrombosis a significant correlation was observed between the VWF and DNA content in thrombi (adjusted-R2 = 0.40), whereas a 3.7-fold lower linear regression coefficient was seen in AIS patients, in whom the fraction of thrombi of atherosclerotic origin was 57%. Independently of anatomical location, in patients with atherosclerosis the VWF in thrombi correlated with the plasma C-reactive protein levels. The observed interrelations between thrombus constituents and systemic inflammatory biomarkers suggest an intricate interplay along the VWF/NET/fibrin axis in arterial thrombosis. •Fibrin, von Willebrand factor (VWF) and NETs form an intertwined matrix in thrombi.•The positive correlation of VWF and DNA in thrombi is reinforced by atherosclerosis.•At higher DNA content the thrombi of smokers are VWF-richer and fibrin-poorer with thinner fibrin fibers.•The fibrin/VWF ratio in thrombi increases with age.•VWF in thrombi with atherosclerotic etiology correlates positively with plasma CRP-levels.</description><subject>Biomarkers</subject><subject>Brain Ischemia</subject><subject>DNA</subject><subject>Fibrin</subject><subject>Humans</subject><subject>Male</subject><subject>Myocardial infarction</subject><subject>Neutrophil extracellular traps</subject><subject>Peripheral artery disease</subject><subject>Stroke</subject><subject>Thrombosis</subject><subject>von Willebrand Factor</subject><issn>0049-3848</issn><issn>1879-2472</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUFv1DAQhS0EokvhL1Q-ckmwY6-T3KgKBaQKLiCO1sQeq16ceLGdLf0z_Fa8bMuV01y-997MPEIuOGs54-rNri23Kc4Jc9uxjrect4zzJ2TDh35sOtl3T8mGMTk2YpDDGXmR844x3vNx-5ycCTlIyaTakN_Xfkp-oSXSQ1zodx8CTgkWSx2YEhNNUHyklYBUMHkI9G_w5KnPFHKOxkNBS-98uaX7AHkGGvCAIdPoqs4FmGeoTvd08nGG9ANTFdaAEE11g2ldLCwGjzj-KgkMhrAGSPTd58uX5JmDkPHVwzwn367ff7362Nx8-fDp6vKmMUJw3sBgQAydcp2xQ-eQWaU4V1I6I-y4Ndbh1KNFoZQ1wikupmm7HTvjLOvHcRDn5PXJd5_izxVz0bPPx0Vgwbhm3SkmhxrFZEXVCTUp5pzQ6X3y9a57zZk-dqN3-rEbfexGc65rN1V48ZCxTjPaf7LHMirw9gTU5-HBY9LZeKyvsT6hKdpG_7-MP0Typ8c</recordid><startdate>202201</startdate><enddate>202201</enddate><creator>Tóth, Erzsébet</creator><creator>Beinrohr, László</creator><creator>Gubucz, István</creator><creator>Szabó, László</creator><creator>Tenekedjiev, Kiril</creator><creator>Nikolova, Natalia</creator><creator>Nagy, Anikó I.</creator><creator>Hidi, László</creator><creator>Sótonyi, Péter</creator><creator>Szikora, István</creator><creator>Merkely, Béla</creator><creator>Kolev, Krasimir</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202201</creationdate><title>Fibrin to von Willebrand factor ratio in arterial thrombi is associated with plasma levels of inflammatory biomarkers and local abundance of extracellular DNA</title><author>Tóth, Erzsébet ; Beinrohr, László ; Gubucz, István ; Szabó, László ; Tenekedjiev, Kiril ; Nikolova, Natalia ; Nagy, Anikó I. ; Hidi, László ; Sótonyi, Péter ; Szikora, István ; Merkely, Béla ; Kolev, Krasimir</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3311-a8ca3826f2cd82fe0d6611644fc3d95cdfeb7ede366dc3f613bb5592cfd079983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Biomarkers</topic><topic>Brain Ischemia</topic><topic>DNA</topic><topic>Fibrin</topic><topic>Humans</topic><topic>Male</topic><topic>Myocardial infarction</topic><topic>Neutrophil extracellular traps</topic><topic>Peripheral artery disease</topic><topic>Stroke</topic><topic>Thrombosis</topic><topic>von Willebrand Factor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tóth, Erzsébet</creatorcontrib><creatorcontrib>Beinrohr, László</creatorcontrib><creatorcontrib>Gubucz, István</creatorcontrib><creatorcontrib>Szabó, László</creatorcontrib><creatorcontrib>Tenekedjiev, Kiril</creatorcontrib><creatorcontrib>Nikolova, Natalia</creatorcontrib><creatorcontrib>Nagy, Anikó I.</creatorcontrib><creatorcontrib>Hidi, László</creatorcontrib><creatorcontrib>Sótonyi, Péter</creatorcontrib><creatorcontrib>Szikora, István</creatorcontrib><creatorcontrib>Merkely, Béla</creatorcontrib><creatorcontrib>Kolev, Krasimir</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Thrombosis research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tóth, Erzsébet</au><au>Beinrohr, László</au><au>Gubucz, István</au><au>Szabó, László</au><au>Tenekedjiev, Kiril</au><au>Nikolova, Natalia</au><au>Nagy, Anikó I.</au><au>Hidi, László</au><au>Sótonyi, Péter</au><au>Szikora, István</au><au>Merkely, Béla</au><au>Kolev, Krasimir</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fibrin to von Willebrand factor ratio in arterial thrombi is associated with plasma levels of inflammatory biomarkers and local abundance of extracellular DNA</atitle><jtitle>Thrombosis research</jtitle><addtitle>Thromb Res</addtitle><date>2022-01</date><risdate>2022</risdate><volume>209</volume><spage>8</spage><epage>15</epage><pages>8-15</pages><issn>0049-3848</issn><eissn>1879-2472</eissn><abstract>The composition of thrombi determines their structure, mechanical stability, susceptibility to lysis, and consequently, the clinical outcome in coronary artery disease (CAD), acute ischemic stroke (AIS), and peripheral artery disease (PAD). Fibrin forms the primary matrix of thrombi intertwined with DNA, derived from neutrophil extracellular traps (NETs), and von Willebrand factor (VWF) bridging DNA and platelets. Here we examined the relative content of fibrin, DNA and VWF in thrombi and analyzed their interrelations and quantitative associations with systemic biomarkers of inflammation and clinical characteristics of the patients. Thrombi extracted from AIS (n = 17), CAD (n = 18) or PAD (n = 19) patients were processed for scanning electron microscopy, (immune)stained for fibrin, VWF and extracellular DNA. Fibrin fiber diameter, cellular components, fibrin/DNA and fibrin/VWF ratios were measured. Patients' age presented as a strong explanatory factor for a linear decline trend of the VWF content relative to fibrin in thrombi from CAD (adjusted-R2 = 0.43) and male AIS (adjusted-R2 = 0.66) patients. In a subgroup of CAD and PAD patients with dyslipidemia and high (above 80%) prevalence of atherothrombosis a significant correlation was observed between the VWF and DNA content in thrombi (adjusted-R2 = 0.40), whereas a 3.7-fold lower linear regression coefficient was seen in AIS patients, in whom the fraction of thrombi of atherosclerotic origin was 57%. Independently of anatomical location, in patients with atherosclerosis the VWF in thrombi correlated with the plasma C-reactive protein levels. The observed interrelations between thrombus constituents and systemic inflammatory biomarkers suggest an intricate interplay along the VWF/NET/fibrin axis in arterial thrombosis. •Fibrin, von Willebrand factor (VWF) and NETs form an intertwined matrix in thrombi.•The positive correlation of VWF and DNA in thrombi is reinforced by atherosclerosis.•At higher DNA content the thrombi of smokers are VWF-richer and fibrin-poorer with thinner fibrin fibers.•The fibrin/VWF ratio in thrombi increases with age.•VWF in thrombi with atherosclerotic etiology correlates positively with plasma CRP-levels.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>34844046</pmid><doi>10.1016/j.thromres.2021.11.011</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0049-3848
ispartof Thrombosis research, 2022-01, Vol.209, p.8-15
issn 0049-3848
1879-2472
language eng
recordid cdi_proquest_miscellaneous_2604833104
source MEDLINE; Elsevier ScienceDirect Journals
subjects Biomarkers
Brain Ischemia
DNA
Fibrin
Humans
Male
Myocardial infarction
Neutrophil extracellular traps
Peripheral artery disease
Stroke
Thrombosis
von Willebrand Factor
title Fibrin to von Willebrand factor ratio in arterial thrombi is associated with plasma levels of inflammatory biomarkers and local abundance of extracellular DNA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T05%3A31%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fibrin%20to%20von%20Willebrand%20factor%20ratio%20in%20arterial%20thrombi%20is%20associated%20with%20plasma%20levels%20of%20inflammatory%20biomarkers%20and%20local%20abundance%20of%20extracellular%20DNA&rft.jtitle=Thrombosis%20research&rft.au=T%C3%B3th,%20Erzs%C3%A9bet&rft.date=2022-01&rft.volume=209&rft.spage=8&rft.epage=15&rft.pages=8-15&rft.issn=0049-3848&rft.eissn=1879-2472&rft_id=info:doi/10.1016/j.thromres.2021.11.011&rft_dat=%3Cproquest_cross%3E2604833104%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2604833104&rft_id=info:pmid/34844046&rft_els_id=S0049384821005193&rfr_iscdi=true